Clinical-stage biopharmaceutical developing HIL-214, a virus-like-particle norovirus vaccine for infants and other at-risk populations.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account